BMA reverses stance on Cass review after internal reassessment of transgender youth care

The British Medical Association (BMA) has reversed its stance on the Cass review, a major assessment of NHS gender identity services for children and young people. The organisation had previously rejected the review’s findings but now accepts its conclusions after an internal reassessment.

The review, led by Dr. Hilary Cass, examined the quality of care provided to transgender youth within the NHS. Its recommendations had faced strong opposition from the BMA until now. The Cass review, published earlier this year, found that gender identity services for under-18s were 'built on shaky foundations'. It warned of a lack of high-quality evidence supporting routine medical interventions, including the use of sex hormones for minors. The report’s 32 recommendations were initially dismissed by the BMA council, which called them 'unsubstantiated'.

A new internal evaluation, carried out by 12 BMA members, has now led to a change in position. Professor David Strain, chair of the BMA’s board of science, described the review process as constructive. He noted that clinicians with differing opinions had engaged respectfully, ensuring the evidence was examined thoroughly.

Strain also emphasised that the review had treated the data and ethical complexities with consistent care. The shift in the BMA’s stance follows months of debate over the review’s implications for transgender healthcare in the UK. The BMA’s decision removes a key barrier to implementing the Cass review’s recommendations. The review had already concluded that young patients had been poorly served by weak evidence and inconsistent care standards. With the BMA no longer opposing the findings, NHS gender services may now face significant changes in how they operate.